Alao, Renna Jane L.

HRN: 26-15-83  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/22/2025
CEFUROXIME 750MG (VIAL)
05/22/2025
05/29/2025
IV
360mg
Q8H
ATP
Waiting Final Action 
05/23/2025
NYSTATIN 100,000IU/ML, 30ML SUSPENSION (BOT)
05/23/2025
05/29/2025
PO
1mL
QID
Apthous Ulcers
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: